Literature DB >> 8147924

Variation among rheumatologists in the use of prednisone and second-line agents for the treatment of rheumatoid arthritis.

L A Criswell1, W J Redfearn.   

Abstract

OBJECTIVE: To test for and estimate variation among rheumatologists in their prescribing of prednisone and second-line agents for the treatment of rheumatoid arthritis (RA), after taking into account the characteristics of their patients.
METHODS: Multiple logistic regression incorporating random effects for rheumatologists, with adjustment for patient characteristics.
RESULTS: Values for the likelihood-ratio statistic provided strong evidence of such variation. Random-effect variance estimates showed that the variation is of great magnitude.
CONCLUSION: Even after patient characteristics have been taken into account, the data show that the rheumatologist may strongly influence the use of prednisone and second-line agents by a patient.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8147924     DOI: 10.1002/art.1780370407

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

1.  Synthetic disease-modifying antirheumatic drug prescribing variability in rheumatoid arthritis: a multilevel analysis of a cross-sectional national study.

Authors:  Iván Ferraz-Amaro; Daniel Seoane-Mato; Fernando Sánchez-Alonso; María A Martín-Martínez
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

2.  A brief history of medical taxonomy and diagnosis.

Authors:  Geza P Balint; W Watson Buchanan; Jan Dequeker
Journal:  Clin Rheumatol       Date:  2006-02-02       Impact factor: 2.980

3.  Variability in Glucocorticoid Prescribing for Rheumatoid Arthritis and the Influence of Provider Preference on Long-Term Use of Glucocorticoids.

Authors:  Michael D George; Joshua F Baker; Beth Wallace; Lang Chen; Qufei Wu; Fenglong Xie; Huifeng Yun; Jeffrey R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-10-07       Impact factor: 4.794

4.  The effect of low-dose prednisone on bone mineral density in Peruvian rheumatoid arthritis patients.

Authors:  Cecilia P Chung; Anthony S Russell; Maria I Segami; César A Ugarte
Journal:  Rheumatol Int       Date:  2003-11-20       Impact factor: 2.631

5.  Patterns of glucocorticoid prescribing and provider-level variation in a commercially insured incident rheumatoid arthritis population: A retrospective cohort study.

Authors:  Beth I Wallace; Paul Lin; Neil Kamdar; Mohamed Noureldin; Rodney Hayward; David A Fox; Jeffrey R Curtis; Kenneth G Saag; Akbar K Waljee
Journal:  Semin Arthritis Rheum       Date:  2019-09-07       Impact factor: 5.532

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.